RAGE: a single receptor fits multiple ligands.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 22019011)

Published in Trends Biochem Sci on October 19, 2011

Authors

Günter Fritz1

Author Affiliations

1: University of Freiburg, Department of Neuropathology, Neurozentrum, Breisacher Str. 64 79106 Freiburg, Germany. guenter.fritz@uniklink-freiburg.de

Articles citing this

HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload. PLoS One (2016) 1.38

Role of advanced glycation end products in cardiovascular disease. World J Cardiol (2012) 1.13

RAGE: a new frontier in chronic airways disease. Br J Pharmacol (2012) 1.04

Polyphosphate amplifies proinflammatory responses of nuclear proteins through interaction with receptor for advanced glycation end products and P2Y1 purinergic receptor. Blood (2013) 0.96

Uremic Toxicity of Advanced Glycation End Products in CKD. J Am Soc Nephrol (2015) 0.94

The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs). PLoS One (2014) 0.93

Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchange. PLoS One (2013) 0.91

S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation. J Biol Chem (2012) 0.90

Soluble receptor for advanced glycation end-products and progression of airway disease. BMC Pulm Med (2014) 0.89

Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging. Aging Dis (2014) 0.87

Is RAGE still a therapeutic target for Alzheimer's disease? Future Med Chem (2012) 0.86

C-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction. J Pharmacol Exp Ther (2012) 0.85

Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells. Front Endocrinol (Lausanne) (2014) 0.85

Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure. Curr Heart Fail Rep (2012) 0.84

Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Mol Metab (2015) 0.82

Advanced Glycation End Products (AGE) Potently Induce Autophagy through Activation of RAF Protein Kinase and Nuclear Factor κB (NF-κB). J Biol Chem (2015) 0.82

Combinatorial library of improved peptide aptamers, CLIPs to inhibit RAGE signal transduction in mammalian cells. PLoS One (2013) 0.81

A multicellular signal transduction network of AGE/RAGE signaling. J Cell Commun Signal (2012) 0.81

The specificity of DNA recognition by the RAGE receptor. J Exp Med (2014) 0.80

Peptide aptamers: development and applications. Curr Top Med Chem (2015) 0.80

Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options. GMS Curr Top Otorhinolaryngol Head Neck Surg (2015) 0.78

The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation. J Immunol Res (2016) 0.78

Role of receptor for advanced glycation end products (RAGE) in liver disease. Eur J Med Res (2015) 0.78

AGEs-Induced IL-6 Synthesis Precedes RAGE Up-Regulation in HEK 293 Cells: An Alternative Inflammatory Mechanism? Int J Mol Sci (2015) 0.78

The role of S100 proteins and their receptor RAGE in pancreatic cancer. Biochim Biophys Acta (2015) 0.78

Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR/Wnt/β-catenin signaling in endothelial cells. J Thromb Haemost (2016) 0.78

Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population. Hypertens Res (2015) 0.77

Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol (2016) 0.77

NMR structure note: the structure of human calcium-bound S100A11. J Biomol NMR (2012) 0.77

Impact of hyperglycemia and acute pancreatitis on the receptor for advanced glycation endproducts. Int J Clin Exp Pathol (2013) 0.77

Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview. J Long Term Eff Med Implants (2014) 0.76

Does Infection-Induced Immune Activation Contribute to Dementia? Aging Dis (2015) 0.76

Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity. Amino Acids (2016) 0.75

The diagnostic utility and tendency of the soluble receptor for advanced glycation end products (sRAGE) in exudative pleural effusion. J Thorac Dis (2016) 0.75

Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts. Antioxid Redox Signal (2015) 0.75

Biodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administration. PLoS One (2013) 0.75

Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast. PLoS One (2016) 0.75

Influence of nonenzymatic posttranslational modifications on constitution, oligomerization and receptor binding of S100A12. PLoS One (2014) 0.75

Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs. Sci Rep (2016) 0.75

The Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE. PLoS One (2016) 0.75

The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis. PLoS One (2016) 0.75

Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study. Immun Ageing (2017) 0.75

Contemporary views on inflammatory pain mechanisms: TRPing over innate and microglial pathways. F1000Res (2016) 0.75

Putative model for heat shock protein 70 complexation with receptor of advanced glycation end products through fluorescence proximity assays and normal mode analyses. Cell Stress Chaperones (2016) 0.75

Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity. Front Pharmacol (2017) 0.75